KIT and gastrointestinal stromal tumor: Subsequently, biallelic loss of DEPDC5 has been found to be common in gastrointestinal stromal tumors with reduced sensitivity to KIT inhibitors, indicating that such alterations can also act as secondary events related to drug resistance.56